Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Liabilities (2016 - 2025)

Haemonetics (HAE) has 16 years of Total Liabilities data on record, last reported at $1.6 billion in Q4 2025.

  • For Q4 2025, Total Liabilities fell 2.77% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 2.77%, while the annual FY2025 figure was $1.6 billion, 31.93% up from the prior year.
  • Total Liabilities reached $1.6 billion in Q4 2025 per HAE's latest filing, down from $1.6 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.6 billion in Q3 2024 and bottomed at $1.1 billion in Q3 2022.
  • Average Total Liabilities over 5 years is $1.3 billion, with a median of $1.1 billion recorded in 2022.
  • The widest YoY moves for Total Liabilities: up 83.77% in 2022, down 6.0% in 2022.
  • A 5-year view of Total Liabilities shows it stood at $1.1 billion in 2021, then dropped by 0.08% to $1.1 billion in 2022, then increased by 14.07% to $1.3 billion in 2023, then increased by 29.22% to $1.6 billion in 2024, then fell by 2.77% to $1.6 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.6 billion in Q2 2025.